173 related articles for article (PubMed ID: 33096795)
1. Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.
Ottaiano A; Caraglia M; Di Mauro A; Botti G; Lombardi A; Galon J; Luce A; D'Amore L; Perri F; Santorsola M; Hermitte F; Savarese G; Tatangelo F; Granata V; Izzo F; Belli A; Scala S; Delrio P; Circelli L; Nasti G
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096795
[TBL] [Abstract][Full Text] [Related]
2. Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
Ottaiano A; Santorsola M; Caraglia M; Circelli L; Gigantino V; Botti G; Nasti G
Transl Oncol; 2021 Aug; 14(8):101131. PubMed ID: 34034007
[TBL] [Abstract][Full Text] [Related]
3. Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Ottaiano A; Circelli L; Lombardi A; Scala S; Martucci N; Galon J; Buonanno M; Scognamiglio G; Botti G; Hermitte F; Savarese G; D'Amore L; Tatangelo F; Di Mauro A; Liguori G; Trotta AM; Napolitano M; Capozzi M; Tafuto S; Perri F; La Rocca A; Caraglia M; Nasti G
Cell Death Dis; 2020 Apr; 11(4):275. PubMed ID: 32332709
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
[TBL] [Abstract][Full Text] [Related]
5. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
6. KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer.
Ottaiano A; Nasti G; Santorsola M; Altieri V; Di Fruscio G; Circelli L; Luce A; Cossu AM; Scognamiglio G; Perri F; Correra M; Belli A; Delrio P; Botti G; Caraglia M
Front Oncol; 2021; 11():632962. PubMed ID: 33854968
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
8. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
[TBL] [Abstract][Full Text] [Related]
9. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
[TBL] [Abstract][Full Text] [Related]
10. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach.
Del Carmen S; Sayagués JM; Bengoechea O; Anduaga MF; Alcazar JA; Gervas R; García J; Orfao A; Bellvis LM; Sarasquete ME; Del Mar Abad M
Oncotarget; 2018 Sep; 9(76):34279-34288. PubMed ID: 30344942
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody.
Adua D; Di Fabio F; Ercolani G; Fiorentino M; Gruppioni E; Altimari A; Rojas Limpe FL; Normanno N; Pinna AD; Pinto C
Mol Clin Oncol; 2017 Jul; 7(1):113-120. PubMed ID: 28685087
[TBL] [Abstract][Full Text] [Related]
13. [Mouse models for human colorectal cancer with liver metastasis].
Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
[No Abstract] [Full Text] [Related]
14. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
[TBL] [Abstract][Full Text] [Related]
16. The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.
Zou SM; Li WH; Wang WM; Li WB; Shi SS; Ying JM; Lyu N
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2149-2159. PubMed ID: 30171333
[TBL] [Abstract][Full Text] [Related]
17. Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.
He Q; Xu Q; Wu W; Chen L; Sun W; Ying J
Onco Targets Ther; 2016; 9():2329-35. PubMed ID: 27143928
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
[TBL] [Abstract][Full Text] [Related]
19. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
20.
Petaccia de Macedo M; Melo FM; Ribeiro HSC; Marques MC; Kagohara LT; Begnami MD; Neto JC; Ribeiro JS; Soares FA; Carraro DM; Cunha IW
Am J Cancer Res; 2017; 7(9):1978-1989. PubMed ID: 28979819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
